BioIntelliSense is a medical technology startup that specializes in remote patient monitoring. The company offers a wearable device, the BioButton, which provides continuous, medical-grade monitoring of a patient's vital signs. This device is designed to be comfortable, discreet, and easy to use, making it an attractive option for patients who require ongoing monitoring but prefer to stay at home. The BioButton collects data that can be analyzed to detect early signs of health issues, enabling proactive medical intervention.

BioIntelliSense primarily serves hospitals, health systems, provider organizations, and payors in the U.S. and select global markets. The company's business model revolves around selling its wearable devices and providing data analytics services. By offering a cost-effective solution for continuous monitoring, BioIntelliSense can help healthcare providers improve patient care while reducing costs associated with hospital stays and emergency interventions.

The company has been recognized for its innovative approach, winning the MedTech Breakthrough Award in 2023 for Best Overall Medical Device Company. It has also established strategic partnerships with other healthcare organizations, such as Ardent Health Services, to expand its reach and impact.

The company is led by Dr. Mault, a seasoned executive with over 35 years of experience in health IT and medical device industry. He has a strong track record of innovation, with over 80 issued and pending patents to his name.

Keywords: Remote Patient Monitoring, Wearable Medical Device, Data Analytics, Proactive Medical Intervention, Healthcare Providers, Cost-Effective, Continuous Monitoring, MedTech Breakthrough Award, Strategic Partnerships, Health IT.